OTOFARMA risk profile
25 Normal where most of the sector sits
Measured 1 September 2026 from OTO.MI's filed statements. Recomputed nightly.
25 (Normal), driven by Market expectation at 68, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 68 | Stretched | Stable | Drawdown from the 52-week high — 57.2% |
| Operating pressure | 22 | Normal | Stable | Costs outgrowing revenue — -5.2 percentage points |
| Cash conversion | 16 | Contained | Stable | Capital spending against operating cash — 0.31x |
| Leverage and coverage | 12 | Contained | Easing | Current ratio — 2.11x |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.